Dynavax Technologies Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy DVAX

*Your capital is at risk

$15.50

+0 (+0%)

At Close: May 08, 2026

Dynavax Technologies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -81.73. In total, the insiders bought 831.44K and sold 21.98M DVAX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-81.73
● Buy	831.44K shares
● Sell	21.98M shares
16% Buy Activity Weak Negative Correlation
Sell Signal High Confidence Feb 10, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -81.73. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (16% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Cano Francis Director	Director	22 500 Value: $262.8K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Cano Francis Director	Director	28 500 Value: $290.1K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Cano Francis Director	Director	22 500 Value: $266.6K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Cano Francis Director	Director	22 500 Value: $252.0K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Cano Francis Director	Director	25 000 Value: $205.0K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Silvernail Lauren P Director	Director	7 125 Value: $72.5K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Silvernail Lauren P Director	Director	42 750 Value: $553.2K
Feb 10, 2026 Sell	Common Stock - Restricted Stock Units D-Return	Silvernail Lauren P Director	Director	10 075 Value: $0
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Macgregor Brent Director	Director	28 500 Value: $290.1K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Macgregor Brent Director	Director	22 500 Value: $266.6K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Spencer Ryan CEO And Director	CEO / President	280 000 Value: $3.11M
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Spencer Ryan CEO And Director	CEO / President	231 000 Value: $2.88M
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Spencer Ryan CEO And Director	CEO / President	225 000 Value: $2.86M
Feb 10, 2026 Sell	Common Stock - Performance Stock Units D-Return	Spencer Ryan CEO And Director	CEO / President	136 000 Value: $0
Feb 10, 2026 Buy	Common Stock - Performance Stock Units A-Award	Slebir John L SVP General Counsel	Officer	50 000 Value: $775.0K
Feb 10, 2026 Sell	Common Stock - Performance Stock Units D-Return	Slebir John L SVP General Counsel	Officer	42 424 Value: $0
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Slebir John L SVP General Counsel	Officer	300 000 Value: $2.79M
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Slebir John L SVP General Counsel	Officer	88 000 Value: $978.6K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Metzinger Joseph Anthony Vp, Chief Accounting Officer	Officer	31 500 Value: $310.3K
Feb 10, 2026 Sell	Restricted Stock Units D-Return	Metzinger Joseph Anthony Vp, Chief Accounting Officer	Officer	25 455 Value: $0
Feb 10, 2026 Sell	Common Stock U-Tender	Metzinger Joseph Anthony Vp, Chief Accounting Officer	Officer	7 129 Value: $0
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Myers Scott Dunseth Director	Director	16 875 Value: $197.1K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Myers Scott Dunseth Director	Director	22 500 Value: $252.0K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Myers Scott Dunseth Director	Director	22 500 Value: $266.6K
Feb 10, 2026 Sell	Stock Option (Right to Buy) D-Return	Myers Scott Dunseth Director	Director	28 500 Value: $290.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT DYNAVAX TECHNOLOGIES CORPORATION

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll...

Read Full Profile Here